Targeting of xkr8 in therapies
AssigneeUniversity of Pittsburgh—Of the Commonwealth System of Higher Education
InventorsSong Li, Yuang Chen
Life of this patent
Estimating the term…
Abstract
A therapeutic system or combination includes a first therapeutic agent to treat a disease condition and a second therapeutic agent adnrinistrable within a predetermined time of administration of the first therapeutic agent the second therapeutic agent inhibiting the function of Xkr8.
Claims29
A therapeutic system or combination comprising a first therapeutic agent to treat a disease condition and a second therapeutic agent administrable within a predetermined time of administration of the first therapeutic agent, the second therapeutic agent inhibiting the function of Xkr8.
-13. (canceled)
(canceled)
(canceled)
The therapeutic system 30 wherein the hydrophobic polymer backbone further comprises a pendant lipidic group.
-52. (canceled)
A formulation, comprising:
- nanostructures formed from self-assembly of a plurality of amphiphilic polymers, a plurality of a first hydrophobic or lipophilic therapeutic agent associated with a core of each of the nanostructures, and a second therapeutic agent which decreases the Xkr8 expression level or inhibits the function of Xkr8.
-88. (canceled)
Dependencies are inferred from the claim text.